ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Montserrat, J.
Right arrow Articles by Rodriguez-Roisin, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montserrat, J.
Right arrow Articles by Rodriguez-Roisin, R
Eur Respir J 1995; 8: 28-33
Copyright © ERS Journals Ltd 1995


Clinical Trial

Gas exchange response to intravenous aminophylline in patients with a severe exacerbation of asthma

JM Montserrat, JA Barbera, C Viegas, J Roca, and R Rodriguez-Roisin

In patients with acute exacerbations of asthma, the intravenous administration of bronchodilators, such as salbutamol, entails the potential risk of worsening pulmonary gas exchange, despite an amelioration of airflow obstruction. The present study was designed to investigate the effect of intravenous aminophylline on pulmonary gas exchange in patients hospitalized with a severe exacerbation of asthma. We studied 12 patients (aged 41 +/- 13 yrs) admitted to the hospital because of an exacerbation of asthma. The study was of a randomized, double-blind, placebo-controlled design. Six patients were treated with intravenous aminophylline and six received placebo, in addition to standard treatment with inhaled salbutamol and intravenous corticosteroids. Forced spirometry, respiratory gas exchange, ventilation-perfusion relationships assessed with the multiple inert gas elimination technique, and systemic haemodynamics were measured at baseline and 60 min after treatment started. In the aminophylline-treated group, mean theophylline plasma levels increased to 15.2 +/- 3.6 micrograms.ml-1, forced expiratory volume (FEV1) increased by 17 +/- 12%, and forced vital capacity (FVC) by 16 +/- 10%. The mean changes in FEV1 and FVC in the aminophylline-treated group were significantly higher than in the placebo-treated group. Likewise, minute ventilation increased by 23 +/- 14% and arterial carbon dioxide tension (PaCO2) decreased by 0.4 +/- 0.3 kPa (3 +/- 2 mmHg) during aminophylline infusion. No significant changes in arterial oxygen tension (PaO2) or in ventilation-perfusion distributions were shown in aminophylline-treated patients.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
ChestHome page
R. S. Ream, L. L. Loftis, G. M. Albers, B. A. Becker, R. E. Lynch, and R. B. Mink
Efficacy of IV Theophylline in Children With Severe Status Asthmaticus
Chest, May 1, 2001; 119(5): 1480 - 1488.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the European Respiratory Society.